On 21 July 2026, Dingdang Health Technology Group Ltd. released an update on its corporate governance structure, confirming the composition of the Board of Directors and the membership of its three standing committees.

The Board now consists of six executive directors—Yang Wenlong (Chairman & President), Yang Yibin, Xu Ning, Yu Qinglong, Meng Fanzhou and Yang Xiao—and three independent non-executive directors—Zhang Shouchuan, Fan Zhenhong and Jiang Shan.

Committee assignments are as follows: • Audit Committee: chaired by independent non-executive director Jiang Shan, with Zhang Shouchuan and Fan Zhenhong as members. • Nomination Committee: chaired by Chairman & President Yang Wenlong and supported by Fan Zhenhong, Zhang Shouchuan, Jiang Shan and Yang Xiao. • Remuneration Committee: chaired by independent non-executive director Fan Zhenhong, with Zhang Shouchuan and Jiang Shan serving alongside.

The announcement confirms that Dingdang Health maintains full compliance with Hong Kong listing requirements for independent oversight, as each committee is led by, or includes, independent non-executive directors.